Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X-ON: Extended-Release vs. Oral Naltrexone for Alcohol Treatment
NCT01893827Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2014
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in alcohol dependence, sponsored by NYU Langone Health. Started Jun 2014; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01893827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01893827.